TrialPloS one2013

miR-150 promotes human breast cancer growth and malignant behavior by targeting the pro-apoptotic purinergic P2X7 receptor.

Songyin Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.